Recombinant interleukin-12, but not granulocyte-colony stimulating factor, improves survival in lethally irradiated nonhuman primates in the absence of supportive care: evidence for the development of a frontline radiation medical countermeasure.

Recombinant interleukin-12, but not granulocyte-colony stimulating factor, improves survival in lethally irradiated nonhuman primates in the absence of supportive care: evidence for the development of a frontline radiation medical countermeasure.

Item
http://www.wikidata.org/entity/Q46213951
γ-Tocotrienol as a Promising Countermeasure for Acute Radiation Syndrome: Current StatusThe Toll-Like Receptor 5 Agonist Entolimod Mitigates Lethal Acute Radiation Syndrome in Non-Human PrimatesMedical countermeasures for unwanted CBRN exposures: part II radiological and nuclear threats with review of recent countermeasure patentsMedical Countermeasures for Radiation Exposure and Related Injuries: Characterization of Medicines, FDA-Approval Status and Inclusion into the Strategic National Stockpile.Recombinant human thrombopoietin promotes hematopoietic reconstruction after severe whole body irradiation.Effect of recombinant interleukin-12 on murine skin regeneration and cell dynamics using in vivo multimodal microscopy.Animal models for acute radiation syndrome drug discovery.A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part II. Countermeasures for limited indications, internalized radionuclides, emesis, late effects, and agents demonstrating efficacy in larNonhuman primates as models for the discovery and development of radiation countermeasures.A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation sub-syndromes, animal models and FDA-approved countermeasures.
P2860

Recombinant interleukin-12, but not granulocyte-colony stimulating factor, improves survival in lethally irradiated nonhuman primates in the absence of supportive care: evidence for the development of a frontline radiation medical countermeasure.

Item
http://www.wikidata.org/entity/Q46213951
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Recombinant interleukin-12, bu ...... iation medical countermeasure.
@en
Recombinant interleukin-12, bu ...... iation medical countermeasure.
@nl
type
label
Recombinant interleukin-12, bu ...... iation medical countermeasure.
@en
Recombinant interleukin-12, bu ...... iation medical countermeasure.
@nl
prefLabel
Recombinant interleukin-12, bu ...... iation medical countermeasure.
@en
Recombinant interleukin-12, bu ...... iation medical countermeasure.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Recombinant interleukin-12, bu ...... iation medical countermeasure.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698